Ep. 145 - What's Next for BIO, Plus: Pfizer, GSK
BioCentury This Week

Ep. 145 - What's Next for BIO, Plus: Pfizer, GSK

Nov 7, 2022
20:57
S3 · E145
-(0)

About this episode

BIO needs to pick a leadership team rather than a leader to give the trade group all the skills it needs moving forward, Washington Editor Steve Usdin said on the latest BioCentury This Week podcast. Usdin and Editor in Chief Simone Fishburn discuss how BIO needs to address the challenges it now faces, as well as the results of BioCentury’s industry-wide survey on the state of the trade group. BioCentury’s podcast team also assess the latest developments in RSV product development, the ...

Comments

Rate this episode

Episode Details

Author
BioCentury
Show Type
full
Audio Format
audio/mpeg

We use analytics

We use Umami, a privacy-friendly analytics tool, to understand how visitors use this site. No personal data is collected and no data leaves our EU servers. You can accept or decline below. Privacy Policy